Possibilities of microneedling in the combined therapy of vitiligo. Literature review

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The Vitiligo therapy is still a topical issue today. According to the Russian and European clinical guidelines, modern therapy for vitiligo includes UVB-311 nm phototherapy, topical glucocorticoids and topical calcineurin inhibitors. Standard treatment regimens require a long time of application and their effectiveness on the average does not exceed 40%, which leads to disappointment in the treatment not only for patients but also for dermatologists. In this regard an active search for therapies for vitiligo continues. Thus, one of the modern options for the treatment of this disease is microneedling.

Microneedling is a relatively new, easy to perform, safe and minimally invasive therapeutic technique that enhances the regenerative process by creating numerous microtraumas occurring when shallow needles are punctured into the skin. This procedure causes a cascade of reactions similar to the wound healing process, stimulating the production of collagen, elastin and growth factors and increases the migration of melanocytes and keratinocytes leading to repigmentation of vitiligo lesions. Local damage to the skin with needles enhances penetration of active ingredients into deeper layers, so microneedling is often combined with the use of UV light, as well as with various biopharmaceuticals to increase efficiency. Although the procedure is relatively new it has demonstrated efficacy, good tolerability, limited undesirable effects and a short recovery time, making micro-needling a promising treatment for vitiligo.

This article is a review in nature. The purpose of this review is to update the available information on the treatment of vitiligo as well as to explore a promising new method of therapy. A systematic literature review was conducted using PubMed, Cochrane Library, CyberLeninka, Clinicaltrial.govand the open-access Internet databases to examine the efficacy, principles of action, and tolerability of the new treatment. Key words used in the literature search in the aforementioned databases were “vitiligo,” “vitiligo treatment,” “microneedling,” and “quality” of life .The results of various clinical studies are presented.

This review is addressed to practicing dermatovenerologists interested in vitiligo therapy.

About the authors

Olga Yu. Olisova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN-code: 2500-7989

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Alena S. Nikulina

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: a.niku@mail.ru
ORCID iD: 0000-0002-0736-8022
SPIN-code: 8652-3101

MD, Graduate Student

Russian Federation, 4-1 Bolshaya Pirogovskaya str., Moscow, 119435

Elizaveta A. Krotkova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: elise1197@mail.ru
ORCID iD: 0000-0001-7343-7252

MD

Russian Federation, Moscow

Polina I. Lazareva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: p.dubrovina@mail.ru
ORCID iD: 0000-0001-7411-763X

Student

Russian Federation, Moscow

Konstantin M. Lomonosov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: lamclinic@yandex.ru
ORCID iD: 0000-0002-4580-6193
SPIN-code: 4784-9730

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

References

  1. Clinical recommendations of the Russian Society of Dermatovenerologists and Cosmetologists. Vitiligo. Moscow; 2020. (In Russ).
  2. Bergqvist C, Ezzedine K. Vitiligo: A review. Dermatology. 2020;236(6):571–592. doi: 10.1159/000506103
  3. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–1212. doi: 10.1111/j.1365-4632.2011.05377.x
  4. Kussainova A, Kassym L, Akhmetova A, et al. Vitiligo and anxiety: A systematic review and meta-analysis. PLoS One. 2020;15(11):e0241445. doi: 10.1371/journal.pone.0241445
  5. Liu J, Tang R, Xiao Y, et al. Meta-analytic review of high anxiety comorbidity among patients with vitiligo. Biomed Res Int. 2021;2021:6663646. doi: 10.1155/2021/666364
  6. Lekayon M, Lomonosov KM. Features of the quality of life of patients suffering from vitiligo. Russian journal of skin and venereal diseases. 2022;25(2):119–125. (In Russ). doi: 10.17816/dv106940
  7. Taieb A, Alomar A, Böhm M, et al. Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Europe´enne des Me´decinsSpe´cialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5–19. doi: 10.1111/j.1365-2133.2012.11197.x
  8. Melnikova YG, Lomonosov KM, Gereykhanova LG. Invasive methods of treatment of vitiligo. Russian journal of skin and venereal diseases. 2018;21(2):113–119. (In Russ). doi: 10.18821/1560-9588-2018-21-2-113-119
  9. Iriarte C, Awosika O, Rengifo-Pardo M, et al. Review of applications of microneedling in dermatology. Clin CosmetInvestig Dermatol. 2017;10:289–298. doi: 10.2147/CCID.S142450
  10. Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016;7(4):244–254. doi: 10.4103/2229-5178.185468
  11. Bykanov AS, Snarskaya ES. Microneedling in the threatment of post-acne symptom complex. Russian journal of skin and venereal diseases. 2021;24(1):79–92. (In Russ). doi: 10.17816/dv62216
  12. Salloum A, Bazzi N, Maalouf D, Habre M. Microneedling in vitiligo: a systematic review. Dermatol Ther. 2020;33(6):e14297. doi: 10.1111/dth.14297
  13. Ziaeifar E, Ziaeifar F, Mozafarpoor S, et al. Applications of microneedling for various dermatologic indications with a special focus on pigmentary disorders: A comprehensive review study. Dermatol Ther. 2021;34(6):e15159. doi: 10.1111/dth.15159
  14. Zduńska K, Kołodziejczak A, Rotsztejn H. Is skin microneedling a good alternative method of various skin defects removal. Dermatol Ther. 2018;31(6):e12714. doi: 10.1111/dth.12714
  15. Nair PA, Arora TH. Microneedling using dermaroller: a means of collagen induction therapy. GMJ. 2014;69:24–27.
  16. Falabella AF, Falanga V. Wound healing. The biology of the skin. New York: Parethenon; 2001. Р. 281–299.
  17. Zduńska K, Kołodziejczak A, Rotsztejn H. Is skin microneedling a good alternative method of various skin defects removal. Dermatol Ther. 2018;31(6):e12714. doi: 10.1111/dth.12714
  18. Fabbrocini G, Fardella N, Monfrecola A, et al. Acne scarring treatment using skin needling. Clin Exp Dermatol. 2009;34(8):874–879. doi: 10.1111/j.1365-2230.2009.03291.x
  19. Majid I, Sheikh G, September PI. Microneedling and its applications in dermatology. London: Informa Healthcare; 2014. Р. 44–49.
  20. Serrano G, Almudéver P, Serrano JM, et al. Microneedling dilates the follicular infundibulum and increases transfollicular absorption of liposomal sepia melanin. Clin Cosmet Investig Dermatol. 2015;8:313–318. doi: 10.2147/CCID.S77228
  21. Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci. 2009; 36(4-5):511–523. doi: 10.1016/j.ejps.2008.12.008
  22. Malik N, Singh Y, Goyal T. A simple office-based procedure for patients with extensive vitiligo. J Am Acad Dermatol. 2016;75(5):e195–e197. doi: 10.1016/j.jaad.2016.02.1243
  23. Salloum A, Bazzi N, Maalouf D, Habre M. Microneedling in vitiligo: A systematic review. Dermatol Ther. 2020;33(6):e14297. doi: 10.1111/dth.14297
  24. Ebrahim HM, Elkot R, Albalate W. Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment. J Dermatolog Treat. 2021;32(8):999–1004. doi: 10.1080/09546634.2020.1716930
  25. Mumtaz H, Anis S, Akhtar A, et al. Efficacy of tacrolimus versus clobetasol in the treatment of vitiligo. Cureus. 2020;12(12):e11985. doi: 10.7759/cureus.11985
  26. Bertolani M, Rodighiero E, de Felici Del Giudice MB, et al. Vitiligo: what’s old, what’s new. Dermatol Reports. 2021;13(2):9142. doi: 10.4081/dr.2021.9142
  27. Ibrahim ZA, Hassan GF, Elgendy HY, et al. Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo. J Cosmet Dermatol. 2019;18(2):581–588. doi: 10.1111/jocd.12704
  28. Chhabra S, Chahar YS, Singh A. A comparative study of microneedling combined with topical 5-fluorouracil versus microneedling alone in treatment of localized stable vitiligo. Indian J Dermatol. 2021;66(5):574. doi: 10.4103/ijd.ijd_130_21
  29. Khater M, Nasr M, Salah S, et al. Clinical evaluation of the efficacy of trichloroacetic acid 70% after microneedling vs intradermal injection of 5-fluorouracil in the treatment of nonsegmental vitiligo; a prospective comparative study. Dermatol Ther. 2020;33(4):e13532. doi: 10.1111/dth.13532
  30. Nofal A, Eldeeb F, Shalaby M, et al. Microneedling combined with pimecrolimus, 5-fluorouracil, and trichloroacetic acid in the treatment of vitiligo: a comparative study. Dermatol Ther. 2022;35(3):e15294. doi: 10.1111/dth.15294
  31. Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189(4):711–718. doi: 10.1084/jem.189.4.711
  32. Hegazy RA, Fawzy MM, Gawdat HI, et al. T helper 17 and Tregs: A novel proposed mechanism for NB-UVB in vitiligo. Exp Dermatol. 2014;23(4):283–286. doi: 10.1111/exd.12369. PMID: 24617827
  33. Rodrigues M, Ezzedine K, Hamzavi I, et al.; Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77(1):1–13. doi: 10.1016/j.jaad.2016.10.048
  34. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: A review. J Photochem Photobiol. 1997;38(2-3):99–106. doi: 10.1016/s1011-1344(96)07454-4
  35. Wu CS, Yu CL, Wu CS, et al. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol. 2004;13(12):755–763. doi: 10.1111/j.0906-6705.2004.00221.x
  36. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol. 1991;97(3):410–416. doi: 10.1111/1523-1747.ep12480997
  37. Ahmad TJ, Rashid T, Rani Z. Needling: an adjunct to narrowband ultraviolet B therapy in localized fixed vitiligo. J Pakistan Association Dermatologists. 2008;18:149–153.
  38. El-Domyati M, Anbar TS, Yehia M, et al. The use of intralesional corticosteroid combined with narrowband ultraviolet B in vitiligo treatment: Clinical, histopathologic, and histometric evaluation. Int J Dermatol. 2022;61(5):582–590. doi: 10.1111/ijd.15940
  39. Thomas KS, Batchelor JM, Akram P, et al. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: Results of the hi-light vitiligo trial. Br J Dermatol. 2021;184(5):828–839. doi: 10.1111/bjd.19592
  40. Batchelor JM, Thomas KS, Akram P, et al. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: Hi-light vitiligo three-arm RCT. Health Technol Assess. 2020;24(64):1–128. doi: 10.3310/hta24640
  41. Suntiparpluacha M, Tammachote N, Tammachote R. Triamcinolone acetonide reduces viability, induces oxidative stress, and alters gene expressions of human chondrocytes. Eur Rev Med Pharmacol Sci. 2016;20(23):4985–4992.
  42. Kim D, Nguyen QT, Lee J, et al. Anti-inflammatory roles of glucocorticoids are mediated by Foxp3+ regulatory T cells via a Mir-342-dependent mechanism. Immunity. 2020;53(3):581–596.e5. doi: 10.1016/j.immuni.2020.07.002
  43. Li L, Ma Q, Li H. Effect of vitiligo treatment using compound glycyrrhizin combined with fractional carbon dioxide laser and topical triamcinolone acetonide on serum interleukin-17 and tissue growth factor-β levels. J Int Med Res. 2019;47(11):5623–5631. doi: 10.1177/0300060519871382
  44. Khashaba SA, Elkot RA, Ibrahim AM. Efficacy of NB-UVB, microneedling with triamcinolone acetonide, and a combination of both modalities in the treatment of vitiligo: A comparative study. J Am Acad Dermatol. 2018;79(2):365–367. doi: 10.1016/j.jaad.2017.12.054
  45. Khojah HM, Alharbi AG, Alshaeri AA, et al. Impact of narrow-band ultraviolet B radiation therapy on the quality of life of patients with vitiligo. J Taibah Univ Med Sci. 2021;16(6):843–848. doi: 10.1016/j.jtumed.2021.04.012
  46. Neinaa YM, Lotfy SS, Ghaly NR, et al. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo. Dermatol Ther. 2021;34(2):e14813. doi: 10.1111/dth.14813
  47. Stanimirovic A, Kovacevic M, Korobko I, et al. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB. Dermatol Ther. 2016;29(5):312–316. doi: 10.1111/dth.12363
  48. Gowda A, Healey B, Ezaldein H, Merati M. A systematic review examining the potential adverse effects of microneedling. J Clin Aesthet Dermatol. 2021;14(1):45–54.

Copyright (c) 2023 Olisova O.Y., Nikulina A.S., Krotkova E.A., Lazareva P.I., Lomonosov K.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies